Lorena Lerner
Equibles does not estimate personal net worth.
About Lorena Lerner
Keros Therapeutics, Inc. reported in an 8-K filed August 6, 2025 that Lorena Lerner was appointed Chief Scientific Officer, effective August 6, 2025. Keros Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Keros Therapeutics, Inc. includes Jasbir Seehra (CEO, Chairman and Board Member), Jean-Jacques Bienaimé (Chairman and Board Member), Annita Tanini (Chief Accounting Officer) and 4 others.
“On August 6, 2025, Keros Therapeutics, Inc. (the "Company") announced that Lorena Lerner, Ph.D., has been appointed to serve as the Company's Chief Scientific Officer, effective as of August 6, 2025.”
Affiliation history
-
Keros Therapeutics, Inc. (KROS)
Proxy statement
CurrentStart not stated–present
Last confirmed April 22, 2026
Company network
Leadership on record at Keros Therapeutics, Inc.
- Jasbir Seehra CEO, Chairman, Board Member
- Jean-Jacques Bienaimé Chairman, Board Member
- Annita Tanini Chief Accounting Officer
- Alpna Seth Board Member
- Anne Prener, M.D., Ph.D. Board Member
- Charles Newton Board Member
- Mary Ann Gray Board Member